Decision Support for BRCA Testing in Ethnically Diverse Women

NACompletedINTERVENTIONAL
Enrollment

276

Participants

Timeline

Start Date

December 13, 2017

Primary Completion Date

August 17, 2020

Study Completion Date

August 17, 2020

Conditions
Breast CancerBRCA1 MutationBRCA2 MutationOvarian Cancer
Interventions
OTHER

RealRisks

RealRisks is a web-based patient decision aid with modules on risk assessment, family history and breast cancer, genetic testing, and prevention options. Participants enter family history data into RealRisks, and RealRisks calculates 5-year breast cancer risk, lifetime breast cancer risk, and the probability of carrying a BRCA mutation. This information is then interactively presented to the participant. RealRisks facilitates the participant in identifying their intention to undergo BRCA genetic testing and the factors that are important to the participant in making this decision. RealRisks produces a summary of all of this information that the participant can print and take with her to a health care appointment.

OTHER

BNAV

BNAV is a web-based decision support tool for healthcare providers with educational modules on genetic testing, chemoprevention, patient-centered care, and screening. BNAV also provides providers with a table outlining their enrolled patients' breast cancer risk, eligibility for genetic testing, and stated preferences.

OTHER

iNYP

Enrolled patients will have their eligibility for BRCA genetic testing flagged in iNYP, the hospital's portal for visualizing EHR data (standard practice).

OTHER

Standard Educational Material

Enrolled patient participants will be sent standard educational brochures on genes and breast cancer and the CUMC breast cancer prevention clinic

OTHER

High-Risk Message

Enrolled patient participants will receive a letter that informs them that they meet eligibility criteria for BRCA genetic testing, outlines prevention options, and recommends discussing genetic counseling referral with their health care provider (standard practice).

Trial Locations (1)

10032

Columbia University Medical Center, New York

All Listed Sponsors
collaborator

American Cancer Society, Inc.

OTHER

lead

Columbia University

OTHER

NCT03470402 - Decision Support for BRCA Testing in Ethnically Diverse Women | Biotech Hunter | Biotech Hunter